Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day

LONDON & SEATTLE--(BUSINESS WIRE)-- #ophthalmology--Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Henric Bjarke, Chief Executive Officer of Tenpoint Therapeutics, will participate in one-on-one meetings at the virtual Citi Biotech Private Access Day on April 24. About Tenpoint Therapeutics Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company dev